Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07284004

Fatty Liver in Long Standing Cholecystectomy

This observational study aims to evaluate the association between long-term cholecystectomy and the development of metabolic dysfunction-associated fatty liver disease (MAFLD) in adult patients. The study will assess the prevalence and severity of hepatic steatosis in individuals who underwent cholecystectomy several years earlier and compare clinical, metabolic, and biochemical parameters to identify potential risk factors. The goal is to determine whether cholecystectomy contributes to metabolic alterations that increase the likelihood of MAFLD in the long term.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-

Exclusion criteria

  • Patients less than 18 years old.
  • Body mass index (BMI) ≤ 25 kg/m2
  • Patients with chronic renal failure.
  • Patients with liver cirrhosis.
  • Patients with acute liver dysfunction.
  • Breast feeding and pregnancy.
  • patients have done cholecystectomy less than 5 years ago.

Treatment and study plan

Primary outcomes

  1. Incidence and severity of metabolic dysfunction-associated fatty liver disease (MAFLD) in patients after long term follow up post cholecystectomy

    Time frame: 5 years post-cholecystectomy

Secondary outcomes

  1. Changes in serum level of ALT in post-cholecystectomy patients

    Time frame: Annually for 5 years

Study contacts

Contact information is provided by the study sponsor or research team.

Yasmeen Ahmed Farrag

CONTACT

[email protected]

201027291125

Sponsors and collaborators

Lead sponsor

Yasmeen Ahmed Farrag Ahmed

Other

Registry information

Official study title

Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patiens

Acronym: MAFLD-Chole St

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 16, 2025
Registry last updated
Dec 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.